We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GSK Halts Trial Enrollment Following Kidney Problems
GSK Halts Trial Enrollment Following Kidney Problems
May 12, 2010
Unexpected safety issues have prompted GlaxoSmithKline (GSK) to stop enrolling patients in a Phase II trial of a possible treatment for multiple myeloma.